There are a number of promising options to prevent PDPH, yet heterogeneity between the studies and publication bias towards small non-RCTs with positive results limits the available evidence. Thus, a large multicentre RCT is needed to determine the best preventative practices.
† All have shown some efficacy; no clear recommendation can be made. † Large, multicentre randomized controlled trials are needed to identify best treatment option.
Summary. No clear consensus exists on how to best prevent severe headache from occurring after accidental dural puncture. We conducted a quantitative systematic review to identify all available evidence for the prevention of postdural puncture headache (PDPH) and included 17 studies with 1264 patients investigating prophylactic epidural blood patch (PEBP), epidural morphine, intrathecal catheters, and epidural or intrathecal saline. The relative risk (RR) for headache after PEBP was 0.48 [95% confidence interval (CI): 0.23 -0.99] in five non-randomized controlled trials (non-RCTs) and 0.32 (0.10 -1.03) in four randomized controlled trials (RCTs). The RR for epidural morphine (based on a single RCT) was 0.25 (0.08-0.78). All other interventions were based on non-RCTs and failed statistical significance, including long-term intrathecal catheters with an RR of 0.21 (0.02 -2.65). There are a number of promising options to prevent PDPH, yet heterogeneity between the studies and publication bias towards small non-RCTs with positive results limits the available evidence. Thus, a large multicentre RCT is needed to determine the best preventative practices.
Keywords: accidental dural puncture; epidural morphine; intrathecal catheters; postdural puncture headache; prophylactic epidural blood patch Postdural puncture headache (PDPH) can occur as a result of diagnostic lumbar puncture, spinal anaesthesia, and accidental dural puncture during epidural anaesthesia. 1 PDPH has the potential to cause significant morbidity in the obstetric patient. Depending on the severity of the headache, the mother may be unable to adequately care for her newborn or herself for quite some time. This condition can also prolong hospital stay for both mother and child and consequently contribute to an increase in the cost of health care in the maternity ward. 2 Several surveys have assessed the rate of accidental dural puncture after epidural catheter placement and recorded frequencies varying from 0.19% to 3.6%. 3 -6 Should accidental dural puncture occur, PDPH develops in more than 50% of these patients. 7 In a national census in the UK, about 6300 obstetric epidural blocks were performed over the course of 2 weeks, translating to 161 550 obstetric epidural blocks annually. 8 9 For a lower end estimate, a 0.9% accidental puncture rate with 50% of those patients experiencing PDPH thus leads to about 800 cases of severe PDPH occurring per year in the UK alone. Conservative measures such as hydration and bed rest have a history of not being very effective. 10 11 Therefore, numerous invasive strategies have instead been suggested to prevent PDPH. A recent survey of clinical practice in the UK showed that the most common invasive prophylactic measures used to minimize the risk of PDPH after accidental dural puncture were long-term intrathecal catheter placement (15%) and epidural saline bolus (13%). The UK survey also demonstrated that the least frequently utilized approach is a prophylactic blood patch (1-2%). 12 A survey of anaesthetists in the USA showed that 19% placed an intrathecal catheter, 12-25% used epidural saline, and 10-31% applied an epidural blood patch as a prophylactic measure.
prophylactic measure is the most effective. The fact that few institutions have a written protocol for managing accidental dural puncture is indicative of this uncertainty. 14 To facilitate this process, we performed a systematic review and meta-analysis of all available evidence for the prevention of PDPH in patients after accidental dural puncture to compare the efficacy of existing strategies in the hope of making an evidence-based recommendation to clinicians.
Methods
We performed a systematic search for studies examining the efficacy of preventative measures for PDPH after accidental dural puncture. We searched PubMed, EMBASE, Science Citation Index, and Cochrane Library databases without any language restrictions using the following free text and associated MeSH terms: (postdural puncture headache AND prevention) OR [dural puncture AND (accidental or inadvertent or unintentional)]. Clinicaltrials.gov was screened for any ongoing unpublished studies that may be relevant, and abstracts and proceedings of major anaesthesia conferences were electronically and hand-searched. References within all identified studies were hand-searched until no new references were found. The last electronic search was performed in January 2010, and when possible, searches included activated weekly e-mail alerts for potentially relevant newly published studies. Articles were reviewed in full by two authors (A.S. and O.R.) for inclusion in the trial and quality of study design. Inclusion criteria were guided by the Cochrane Handbook for Systematic Reviews and were as follows: the focus study population was defined as patients receiving an epidural who had accidental dural puncture, and an invasive preventative measure must have been administered and the incidence of PDPH must have been reported in a dichotomous form.
Studies were excluded if there was no control group. Studies with intentional spinal punctures for diagnostic purpose were also excluded. Since most interventions for PDPH are conspicuous and sham procedures are rarely performed, blinding was not mandatory for studies to be included.
The primary outcome for our analysis was the incidence of PDPH, which was generally defined as headache occurring after dural puncture that may or may not be positional in its nature. A secondary outcome was the need for a therapeutic epidural blood patch as a surrogate outcome for the severity of headache.
The study results and data about the study design were extracted from each trial with the use of manufactured forms. If data or methodological details were absent, the first author was contacted. If after two attempts at contact no reply was given, the trials were only included if sufficient information was available. Studies were grouped whenever possible. For studies with more than one study group, only groups of relevance for this review were included.
Statistical analysis was performed using Cochrane Collaborations Review Manager 5 software [Review Manager (RevMan), Version 5.0.14, Copenhagen: the Nordic Cochrane Centre, The Cochrane Collaboration, 2008] . A random effects model was used for the calculation of relative risks (RRs), the ratio of the risk of PDPH in the group who received a prophylactic intervention compared with the control group. An RR below 1 indicates a potentially beneficial effect for the intervention. All estimates are given as RRs with 95% confidence intervals (CIs). When the 95% CI around the risk ratio did not include the number 1, we assumed a statistically significant difference between the preventative measure and the control.
For sensitivity analyses, we further explored the data for the prophylactic epidural blood patch (PEBP) by separating the included trials into randomized controlled trial (RCT) or non-randomized controlled trial (non-RCT). With the exception of epidural morphine (where there was one RCT), all other interventions were based on non-RCTs, so that a sensitivity analysis was not applicable here. In addition, we performed a funnel plot to visualize a potential source for publication bias.
Results
Twenty-nine studies met the inclusion criteria, but 12 were excluded for lack of a control group. A total of 17 studies, in particular 15 full papers and two abstracts, were included in our review (Table 1 , Fig. 1A and B) . These 17 studies fit into the following five intervention groupings: one with epidural morphine, 15 nine with PEBP, 16 -24 three with epidural saline, 18 24 25 one with intrathecal saline, 26 and six with intrathecal catheter placement. 20 27 -31 Three studies were used to gather data on more than one intervention, with each intervention being compared with the same control group. 18 20 24 In total, 1264 patients enrolled in 17 studies are considered in this analysis.
Epidural morphine
The utility of epidural morphine was investigated in only one RCT. 15 Epidural morphine 3 mg was given after the end of anaesthesia and another 3 mg was given on the following day. This reduced the incidence of PDPH from 48% (12/25) to 12% (3/25), which translates to a statistically significant reduction in the RR of 0.25 (0.08 -0.78). There was no respiratory depression, but nausea was numerically more frequent in the morphine group (44% vs 16%, P¼0.06).
Prophylactic epidural blood patch
In five non-RCTs, the use of a PEBP was associated with a significant reduction in PDPH, giving an RR of 0.48 (0.23 -0.99, Fig. 1A ). 16 18 20 22 24 However, pooled results of the other four randomized trials failed to show statistical significance with an RR of 0.32 (0.10-1.03), but there was significant heterogeneity in the study results (P,0.001, Fig. 1B ). 17 19 21 23 Overall, 5-20 ml of blood was used for the blood patch during the studies (Table 1 , 'comment'). The four RCTs used 15-20 ml of blood for the blood patch, 17 19 21 23 while the 
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On the basis of a number of studies, threading the catheter through the dural hole and using it as an intrathecal catheter do not reduce the incidence of PDPH when removed on the same day (RR¼0.88, 0.68-1.14). 27 -29 -31 Interestingly, two comparisons suggested a significant reduction in PDPH when the catheter was left in place for at least 24 h, 27 28 yet a much larger analysis 20 found no protective effect.
This leads to a pooled RR for the development of PDPH that is no longer statistically significant (RR¼0.21, 0.02 -2.65).
As in the epidural blood patch studies, the results are highly heterogeneous (P,0.001, Fig. 1A ).
Saline
The RR from three studies investigating the use of epidural saline as a preventative measure against PDPH failed to reach statistical significance, with a value of 0.65 (0.40 -1.05). 18 24 25 The one study exploring the intrathecal injection of 10 ml saline for the prevention of PDPH similarly failed to reach statistical significance (RR¼0.51, 0.26 -1.03).
26
Pooled results for both non-RCTs and RCTs showed evidence for heterogeneity at P,0.05. In addition, skew of the funnel plot to the left of the line of unity (i.e. 1.0) suggests a publication bias towards small non-RCTs with positive results (Fig. 2) . The RRs for our secondary outcome, the need for a therapeutic epidural blood patch, are shown in Table 2 .
Discussion
The majority of interventions investigated showed at least some efficacy for the prevention of PDPH, but the immediate placement of an intrathecal catheter or the use of a PEBP before catheter removal demonstrated the best risk/benefit ratio. However, study results are heterogeneous, and there is strong evidence for a publication bias. Thus, no clinical recommendations for how to best avoid PDPH after accidental dural puncture can be made until the superiority of one preventative intervention over another has been unequivocally proven in a definitive multicentre RCT.
PDPH is described as a bilateral, non-throbbing pain, usually fronto-occipital, which is aggravated in the standing position and alleviated in the supine position. 32 It usually develops within 24 h, but emergence up to 7 days has also been described. 7 Accompanying symptoms may include nausea, vomiting, visual disturbances, and altered hearing. The most likely cause of PDPH is cerebral venous dilation. It is assumed that dilation occurs due to a loss of cerebral spinal fluid (CSF) pressure as the CSF seeps through the dural tear caused by the large diameter epidural needle used to enter the epidural space. Although studies have examined interventions that could reduce the size of this tear in the event of dural puncture, 33 -35 the focus of our analysis was on tactics for preventing PDPH that are applied after accidental dural puncture occurs. The use of epidural morphine has only been investigated in one RCT. 15 Although this result has the highest risk reduction of all interventions studied, the only other evidence supporting morphine as a prophylaxis for PDPH after accidental dural puncture comes from two case reports. 36 37 As a caveat, epidural morphine administration was associated with an increased incidence of nausea and itching; however, no respiratory depression was observed. Unfortunately, the study is too small to fully assess the risk/benefit ratio of this intervention. Epidural morphine may thus be a beneficial treatment option, but further studies are needed. Of all the interventions, PEBP has been studied the most extensively, with nine studies included in our analysis. 
Long-term intrathecal catheter vs no intrathecal catheter
Craft and colleagues 25 Cohen and colleagues 28 Norris and Leighton 29 Ayad and colleagues 27 Rutter and colleagues 31 Paech and colleagues 30 Trivedl Volumes between 7.5 and 30 ml are commonly used in clinical practice to perform epidural blood patching, but 5-20 ml was used in the studies analysed here. 3 If all studies were taken together, the RR for PDPH after PEBP was 0.41 (0.24 -0.71). At first glance, these findings support the proposed mechanism for the PEBP: that coagulation of the injected blood will clog the dural tear and stop the leakage of CSF. However, because efficacy results showed significant heterogeneity across the studies (P,0.001), we conducted a sensitivity analysis dependent on whether the studies were randomized or not. As a consequence, the pooled results from the non-RCTs remained statistically significant whereas those of the four RCTs were no longer statistically significant. 17 19 21 Interestingly, the first three RCTs showed a clear reduction in PDPH but had methodological limitations, while the largest and most thoroughly conducted trial found the same incidence of PDPH (18/32) in both the prophylactic and placebo groups. 23 In addition, a recently updated Cochrane Review of the epidural blood patch for preventing and treating PDPH also found conflicting results on the efficacy of the PEBP and concluded that there is insufficient evidence to recommend its use. 38 However, it should be noted that the Cochrane Review was not focused on the typically more severe and frequently occurring headache that develops after inadvertent epidural puncture with the large and sharp needles that are used for the placement of epidural catheters.
As a result, it may have been the limited number of symptomatic patients and consequently low power that made it impossible to more confidently quantify the potential benefit of the PEBP. The failure of a prophylactic blood patch to reduce PDPH appears consistent with a retrospective analysis from the late 1970s that described a 71% failure rate of a therapeutic blood patch when applied within 24 h after puncture, as opposed to only a 4% failure rate when applied later than 24 h. 39 With this in mind, a more recent paper is considered to provide additional evidence of an early blood patch leading to a higher failure rate. 40 However, while a delay in applying the therapeutic blood patch of ,4 days was associated with a higher failure rate, the failure rate was only about 10% when given within the first 2 days. Moreover, taking failure and incomplete relief together, the failure rate was generally more than 30%, irrespective of the time of administration. Therefore, there is limited evidence that the efficacy of an epidural blood patch is markedly influenced by the timing of application. There are several theories as to how intrathecal catheters can prevent PDPH. One hypothesis is that the large-bore intrathecal catheter plugs the dural tear, thereby lessening or stopping the CSF leak from the subarachnoid space and maintaining the intrathecal volume. 26 41 Another possibility was inspired by pathological findings in cats, which showed an inflammatory response within the spinal cord when a catheter was left in place for at least 5 days. 42 Together with the observation of a low incidence of PDPH after continuous spinal anaesthesia for an extended period of time, it was hypothesized that an inflammatory reaction in the dura surrounding the puncture site may facilitate sealing of the hole and prevent leakage of the CSF. 43 However, in one study, we analysed the catheters that remained in place for only 5 h, so it is unclear whether the low incidence can be explained by the inflammation theory or is better explained by the type of surgery. For instance, the mechanics of orthopaedic surgery are less likely to be associated with a leak of the CSF compared with expulsive efforts of a vaginal delivery in obstetrics. The RR reduction of PDPH was not significant in the shortterm catheter group, in which the catheter was left in place for ,24 h and usually removed immediately after delivery. Two non-RCTs examining the effects of long-term catheters reported strong preventative effects, with one reporting a reduction of PDPH from more than 90% to ,10% when the catheter was left in place for at least 24 h. 27 However, a subsequent analysis of a much larger data set was unable to detect any benefit, causing the pooled results of long-term catheters to fail statistical significance. 20 Given the heterogeneity of the study results, the long-term intrathecal catheter might still be a treatment option, beneficial to our patients. However, the direct or indirect evidence is insufficient to provide a strong recommendation. The injection of saline solution into the epidural space is believed to temporarily equilibrate the pressure, which should minimize the leakage of CSF through the dural tear long enough for a fibrin seal to block the aperture.
44 Table 2 RRs and 95% CIs (RR ,1 favours the intervention whereas RR .1 favours the control group) for the primary outcome (PDPH) and secondary outcome (TEBP). PDPH, postdural puncture headache; TEBP, therapeutic epidural blood patch; CI, confidence intervals However, the pooled RR reduction from this intervention failed significance, with only a non-randomized study 25 having a statistically significant result. The other two studies 18 24 failed to produce significant findings. A possible cause for the heterogeneity in the findings is that the non-randomized study 25 injected 60 ml of saline through the catheter on two occasions, immediately after delivery and also the next morning, compared with a single prophylactic saline patch of 40-60 ml. 24 This inconsistency is mirrored in the other study 18 where some patients received bolus injections of 40-60 ml every 6 h for 24 h whereas others received an epidural infusion of 1.5-2 litre over 24 h. Either way, neither of these strategies significantly reduced the risk of headache. A non-randomized study examined the effects of injecting 10 ml of saline intrathecally immediately after accidental dural puncture. 26 The hypothetical mechanism behind this approach is that the increased CSF pressure results in approximation of the dura and arachnoid at the puncture site, which seals the aperture and limits the loss of CSF volume. While the risk was cut by almost half in patients who received the 10 ml saline, this did not reach statistical significance and one can only speculate that injection of a larger volume of saline may have been more effective. However, the study did find that the need for therapeutic epidural blood patch was significantly reduced, suggesting that the intervention at the very least reduced the severity of the headaches. There are some limitations to our analysis. Because accidental dural puncture is a rare complication, it is inherently difficult to conduct well-powered RCTs and it is not surprising that the majority of studies were non-RCTs. Therefore, we conducted sensitivity analyses for RCTs and non-RCTs only where appropriate, which turned out to be only the case for the PEBP. In addition, efficacy measures were mostly heterogeneous across studies, that is, differences in efficacy measures across the studies cannot be explained by random effects (chance) only. We constructed a funnel plot and found that the treatment effect was inversely related to the standard error of the study (Fig. 2) . This means that there is evidence of a significant publication bias towards smaller trials being published if their results are positive. In fact, PEBP appeared highly effective in small trials but less (or not) effective in a larger and well-designed RCT. 23 Similarly, long-term intrathecal catheter appeared to be quite effective in two smaller trials but was found to be less (or not) effective in a much larger study. 20 Given that accidental dural puncture may lead to PDPH in at least 50% of cases, we believe that prophylactic action is justified to prevent any possible morbidity that may occur in the obstetric patient. Since the headaches can be severe enough to prevent the mother from taking care of her newborn and can increase the cost of health care by lengthening hospital stay, it might be more prudent to take a proactive approach by administering preventative measures rather than waiting to begin treatment once the symptoms appear. However, it is important that the prophylactic procedure itself is not associated with significant risks, a consideration worth incorporating into future risk/benefit analyses.
Although study results for both PEBP and intrathecal catheters were heterogeneous, several studies did have promising results. However, the strong evidence for a publication bias among the clinical trials included in this meta-analysis necessitates a cautious interpretation of these results. To avoid the potential downfalls related to a meta-analysis of small RCTs, a properly designed RCT with sufficient power is needed to gain a better understanding of various preventive measures for PDPH.
The results of this meta-analysis have given us the best available evidence for the efficacy of individual interventions for PDPH prevention. Future clinical trials should focus on rigorously comparing the more substantially supported treatment and prophylaxis options, for example, intrathecal catheter, epidural blood patch, or morphine. In addition to providing direction for PDPH research, the results of this study may also be used for the sample size analyses of future studies. It will also be of great interest to compare proactive preventative measures with reactive symptomatic treatment options, a comparison that has the potential to provide valuable information to generate firm PDPH management guidelines.
In conclusion, we have summarized all available evidence for the prevention of PDPH. The largest effect was seen in a single RCT using epidural morphine as a preventative measure. However, these results need to be repeated before firm recommendations can be made. Data on longterm intrathecal catheters and epidural blood patch show potential, but the results are too heterogeneous to make firm recommendations. In addition, there is strong evidence of a publication bias that necessitates a cautious interpretation of these results. A large, well-designed, double-blind, randomized controlled multicentre trial is recommended to provide clinical evidence for the effectiveness of the most promising treatment options, for example, intrathecal catheter, epidural blood patch, and morphine.
